Cardiovascular Risk Evaluation and Antiretrovirals in HIV

NCT01015092 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1024

Last updated 2009-11-17

No results posted yet for this study

Summary

The purpose of the study is to determine the main factors contributing to predicted 10 year cardiovascular risk in an HIV infected cohort, and the role of anti-HIV drug use in altering this risk

Conditions

  • Cardiovascular Risk
  • HIV Infections

Sponsors & Collaborators

Principal Investigators

  • Barry S Peters, MB BS. MD · King's College London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2006-09-30
Completion
2006-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01015092 on ClinicalTrials.gov